Current Treatment Options for Relapsed/Refractory Multiple Myeloma.

The article focuses on the treatment options for relapsed/refractory multiple myeloma (MM). Topics discussed include the criteria for choosing treatment in relapsed/refractory MM patients, the different structural classes of proteasome inhibitors (PIs), including boronates and salinosporamides, and the effects of immunomodulatory agents in relapsed/refractory MM. Also mentioned is the possible role of monoclonal antibodies (mAbs) and other immunotherapies in treating this condition.